Navigation Links
Genta Incorporated Announces Second Quarter 2008 Financial Results and Corporate Highlights
Date:8/7/2008

tor Relations

info@genta.com

Genta Incorporated

Selected Condensed Consolidated Financial Data

(In thousands, except per share data)

(Unaudited)

Three Months Ended Six Months Ended

June 30 June 30

2008 2007 2008 2007

Product sales - net $131 $105 $248 $199

Cost of goods sold 29 26 54 48

Gross margin 102 79 194 151

Operating expenses:

Research and development 4,454 4,099 10,891 7,481

Selling, general and

administrative 2,587 4,735 6,225 8,787

Settlement of office lease

obligation 3,307 - 3,307 -

Reduction in liability for

settlement of litigation (80) (240) (340) (1,800)

Total operating expenses 10,268 8,594 20,083 14,468

Amortization of deferred

financing costs (840) - (840) -

Fair value - conversion

feature liability (720,000) - (720,000) -

Fair value - warrant

liability (7,200) - (7,200) -

All other income/(expense),

net (158) 280 (92) 478

Net loss $(738,364) $(8,235) $(748,021) $(13,839)

Net loss per basic and diluted

share $(20.10) $(0.27) $(21.21) $(0.48)

Weighted average shares - basic

and dilut
'/>"/>

SOURCE Genta Incorporated
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Genta Announces Second Quarter 2008 Financial Results and Conference Call
2. Genta Receives Notice of Allowances for European Patents Related to Composition and Processes for Tesetaxel, a Leading Oral Taxane
3. Genta Submits NDA Amendment to FDA for Genasense as Treatment of Chronic Lymphocytic Leukemia
4. Genta Secures Up to $40 Million Convertible Financing Facility to Fund Key Programs
5. Genta Incorporated Announces First Quarter 2008 Financial Results and Corporate Highlights
6. Genta Announces Transfer of its Common Stock to the OTC Bulletin Board
7. Genta Announces Pending Transfer of its Common Stock to the Over-the-Counter Bulletin Board
8. Dr. Elizabeth Brown Joins Argenta TEC
9. Syngenta To Build Major Global Biotech Research Center in Beijing, China
10. Genta Restructures Operations to Focus on Priority Initiatives
11. Genta Granted Extension to Achieve Compliance with NASDAQ Listing Requirements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/17/2013)... Miami, FL (PRWEB) June 17, 2013 As ... Action are committed to finding a cure all for acne, ... Month, the AARS (Acne and Rosacea Society) ... skin conditions, and helping to educate the public on treatment ... leading society by announcing their daily news updates via social ...
(Date:6/17/2013)... 17, 2013 /PRNewswire-iReach/ -- The latest research on stuttering ... to explore the neurophysiological nature of stuttering, its connection ... such as bullying and teasing. (Photo: ... their latest findings at the National Stuttering Association,s 2013 ... More than 75 speech professionals and researchers ...
(Date:6/17/2013)... The ALS Therapy Development Institute (ALS TDI) will hold ... event on July 19-21, 2013. The Tri-State Trek is a three-day, ... to Greenwich, CT with the mission to ... disease). (Logo: http://photos.prnewswire.com/prnh/20110204/DC42625LOGO ) ... passes through 46 communities and includes 12 rest stops, ...
(Date:6/17/2013)... June 17, 2013 Yongye International, Inc. (NASDAQ: ... manufacturer, and distributor of crop nutrient products in ... announced today that its common stock will resume trading ... 2013 at 7:15 a.m. Eastern Time. As ... on Monday, March 18, 2013 following Yongye,s notification that ...
Breaking Biology Technology:Acne and Rosacea Awareness Month: Probiotic Action Announces their Daily News Updates with Insight on the Most Common Skin Conditions 2New Research On Stuttering Jul 2-3 At Arizona Symposium 2New Research On Stuttering Jul 2-3 At Arizona Symposium 3ALS TDI Tri-State Trek Charity Bike Ride to Take Place July 19-21 2ALS TDI Tri-State Trek Charity Bike Ride to Take Place July 19-21 3Yongye International, Inc. Announces Common Stock Will Resume Trading on the NASDAQ Stock Market on June 17, 2013 2Yongye International, Inc. Announces Common Stock Will Resume Trading on the NASDAQ Stock Market on June 17, 2013 3Yongye International, Inc. Announces Common Stock Will Resume Trading on the NASDAQ Stock Market on June 17, 2013 4
... a new study conducted at the Pennington Biomedical Research Center, ... over the past fifty years is a significant contributor to ... intake cannot solely account for observed trends in weight gain ... The study, entitled "Trends Over 5 Decades in U.S. ...
... Rules-Based Medicine (RBM), a global leader in biomarker ... achieved a significant milestone in a companion diagnostic ... Roche clinical trial, the RBM DiscoveryMAP® platform, and ... was identified that has utility in prognosis of ...
... May 25, 2011 WaferGen Biosystems, Inc. (OTCBB:WGBS), ... today announced it has entered into definitive agreements ... Point Partners, LLC, Deerfield Management and Merlin Nexus, ... in a $30.4 million private placement financing of ...
Cached Biology Technology:Pennington Biomedical Research Center Study Suggests Decreases in U. S. Occupation Energy Levels a Significant Trigger of Obesity Epidemic 2Pennington Biomedical Research Center Study Suggests Decreases in U. S. Occupation Energy Levels a Significant Trigger of Obesity Epidemic 3Rules-Based Medicine Reaches a Significant Milestone in Companion Diagnostic Program With Roche 2WaferGen Announces $30 Million Financing 2WaferGen Announces $30 Million Financing 3WaferGen Announces $30 Million Financing 4
(Date:6/17/2013)... the topics under discussion during the E3 Forum, ... consecutive year, this will be a unique event ... members of Academy, Business, Educators, Entrepreneurs, Innovators, Policy-makers ... Martn Garijo (IBM South Europe), Chris Zegras (MIT), ... (Hovione), among others. E3 Forum - Education, Employment ...
(Date:6/16/2013)... sex workers in India reduce rates of syphilis, HIV ... Toronto study has found. , About two ... southern states of Andhra Pradesh, Karnataka, Maharashtra and Tamil ... U of T,s Dalla Lana School of Public Health ... (CGHR), examined the impact of prevention among female sex ...
(Date:6/15/2013)... in Europe to treat osteoporosis has now been shown ... in cancers that have become resistant to current targeted ... The findings, presented June 15, 2013, at the annual ... drug bazedoxifene packs a powerful one-two punch that not ... but also flags the estrogen receptor for destruction. , ...
Breaking Biology News(10 mins):'E3 Forum -- Education, Employment & Entrepreneurship on a Global context' 2HIV prevention among female sex workers in India reduces HIV and syphilis 2Osteoporosis drug stops growth of breast cancer cells, even in resistant tumors 2
... Institut de recherches cliniques de Montréal (IRCM) have ... determines susceptibility to candidiasis, a common and often ... immunodeficiency virus (HIV). These findings, revealed using a ... developed by the same research group, represents a ...
... at the University of York have made a huge leap ... research group in the Department of Biology has made a ... a type of biological warfare. , Bacteria like E. coli ... using protein antibiotics called colicins, which are potent toxins. ...
... has developed a small, relatively inexpensive "seeing machine" that ... like her, to access the Internet, view the face ... Recently the machine received positive feedback from 10 visually ... vision loss who tested it in a pilot clinical ...
Cached Biology News:Montreal researchers identify defects of immune cells 2MIT 'seeing machine' offers hope to blind 2MIT 'seeing machine' offers hope to blind 3MIT 'seeing machine' offers hope to blind 4
MOUSE ANTI HUMAN C-MYC aa171-188...
MOUSE ANTI SIMIAN VIRUS 5 Immunogen: Simian virus 5...
ANTI ALPHA FSH:B...
... Serum • Beagle serum is collected from ... year of age Available Anticoagulants: ... N-06: K2EDTA N-08: Potassium ... Alsevers N-05: ACD N-07: ...
Biology Products: